News

ON THIS PAGEShared FeaturesCan You Have Both Psoriasis and RA?Which Do You Have?TreatmentWhen to See a RheumatologistPsoriasis and rheumatoid arthritis are both autoimmune diseases. While they affect ...
Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, ...
Medically reviewed by Anita C. Chandrasekaran, MD Psoriatic arthritis (PsA) is a chronic (long-lasting) condition that ...
This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic ...
Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints ...
Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on treatment options and daily management.
Researchers have found in a new canadian prospective cohort study that high sensitivity C-reactive protein (hsCRP) may serve ...
Degenerative disc disease is common among young adults with PsA, with key risk factors including older age, male sex, diabetes, and inflammatory back pain.
Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the ...
Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the ...
Ultrasound-detected dactylitis lesions may help identify patients with psoriasis who are at risk for psoriatic arthritis and ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...